688578 Shanghai Allist Pharmaceuticals Co., Ltd.
- 51.31
- -1.70-3.21%
Shanghai Allist Pharmaceuticals Co., Ltd. News
Announcement of Shanghai Alice Pharmaceutical Technology Co., Ltd. on the election of non-independent directors
Notice of Shanghai Alice Pharmaceutical Technology Co., Ltd. on convening the 2024 First Extraordinary General Meeting of Shareholders
Announcement of Shanghai Alice Pharmaceutical Technology Co., Ltd. on the change of sponsor representative
Announcement of Shanghai Alice Pharmaceutical Technology Co., Ltd. on signing a pharmaceutical technology licensing and development agreement with Gacos
Announcement of Shanghai Allist Pharmaceuticals Co., Ltd. regarding receipt of arbitration notice.
Announcement of Resignation of Non-Independent Directors from Shanghai Allist Pharmaceuticals Co., Ltd.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Shanghai Alice Pharmaceutical Technology Co., Ltd.
Legal Opinion of Shanghai Tongli Law Firm on the 2023 Annual General Meeting of Shareholders of Shanghai Alice Pharmaceutical Technology Co., Ltd.
Materials of the 2023 Annual General Meeting of Shareholders of Shanghai Alice Pharmaceutical Technology Co., Ltd.
Report of the Audit Committee of the Board of Directors of Shanghai Alice Pharmaceutical Technology Co., Ltd. on the performance of supervisory duties by the accounting firm in 2023
Shanghai Alice Pharmaceutical Technology Co., Ltd. 2024 “Improve Quality, Increase Efficiency and Value Return” Action Plan
Announcement of Shanghai Alice Pharmaceutical Technology Co., Ltd. on holding a briefing on the results and cash dividends for the first quarter of 2023 and 2024
Announcement of Shanghai Alice Pharmaceutical Technology Co., Ltd. on revising the “Articles of Association” and formulating part of the company's governance system
Rules of procedure for the board of directors of Shanghai Alice Pharmaceutical Technology Co., Ltd.
Announcement of Shanghai Alice Pharmaceutical Technology Co., Ltd. on the adjustment of audit committee members of the company's board of directors
Notice of Shanghai Alice Pharmaceutical Technology Co., Ltd. on holding the 2023 Annual General Meeting of Shareholders
Shanghai Alice Pharmaceutical Technology Co., Ltd. 2023 Internal Control Evaluation Report
Report on the performance of the Audit Committee of the Board of Directors of Shanghai Alice Pharmaceutical Technology Co., Ltd. in 2023
Shanghai Alice Pharmaceutical Technology Co., Ltd. voluntarily disclosed an announcement on the inclusion of first-line treatment indications for NSCLC with EGFR20 exon insertion mutation in vormetinib mesylate tablets as a proposed breakthrough treatment
Notice of voluntary disclosure by Shanghai Alice Pharmaceutical Technology Co., Ltd. on the renewal of the contract for fumetinib mesylate tablets and inclusion in the national medical insurance catalogue
Analysis
Price Target
No Data
No Data